Surmodics | SRDX - 应收帐款人





应收帐款人 更改 日
Abbott USD 10.57B 171M 2025-12
Align Technology USD 1.13B 23.36M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Artivion USD 103.68M 6.31M 2025-12
Baxter International USD 1.7B 310M 2026-03
Boston Scientific USD 2.93B 98M 2025-12
EDAP TMS EUR 19.02M 498K 2025-09
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Haemonetics USD 195.71M 11.36M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
J&J USD 21.33B 3.72B 2025-12
Merit Medical Systems USD 227M 3.39M 2026-03
Mesa Laboratories USD 40.23M 4.66M 2024-09
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Option Care Health USD 516.44M 42.87M 2026-03
Stryker USD 3.57B 468M 2026-03
Surmodics USD 23.56M 288K 2025-06
Trinity Biotech USD 15.02M 3.7M 2025-09